Cargando…

Current vaccine strategies against SARS_CoV-2 only poorly protect kidney transplant recipients

Detalles Bibliográficos
Autores principales:	DUCLOUX, Didier, BAMOULID, Jamal, CHABANNES, Melchior, COLLADANT, Mathilde, MUNSHI, Abdulaziz, ROUBIOU, Caroline, SEIBEL, Jean, TACHIKART, Amine, YANNARAKI, Maria, CREPIN, Thomas, COURIVAUD, Cécile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779864/ https://www.ncbi.nlm.nih.gov/pubmed/35074507 http://dx.doi.org/10.1016/j.jinf.2022.01.020

Ejemplares similares

Triglyceride-Glucose Index and Cardiovascular Events in Kidney Transplant Recipients
por: Colladant, Mathilde, et al.
Publicado: (2023)

Factors associated with humoral response after BNT162b2 mRNA COVID-19 vaccination in kidney transplant patients
por: Ducloux, Didier, et al.
Publicado: (2021)

Humoral response after BNT162b2 mRNA COVID-19 vaccination in patients on haemodialysis depends on immune status
por: Ducloux, Didier, et al.
Publicado: (2021)

Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis
por: Ducloux, Didier, et al.
Publicado: (2021)

Acute kidney injury in non-critical care setting: elaboration and validation of an in-hospital death prognosis score
por: Bamoulid, Jamal, et al.
Publicado: (2019)

Reversible Fluindione-Induced Chronic Interstitial Nephritis
por: Crepin, Thomas, et al.
Publicado: (2016)

End-Stage Renal Disease-Related Accelerated Immune Senescence: Is Rejuvenation of the Immune System a Therapeutic Goal?
por: Ducloux, Didier, et al.
Publicado: (2021)

Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis
por: Ducloux, Didier, et al.
Publicado: (2017)

Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation
por: Courivaud, Cécile, et al.
Publicado: (2020)

ESRD-associated immune phenotype depends on dialysis modality and iron status: clinical implications
por: Ducloux, Didier, et al.
Publicado: (2018)

Pre-transplant immune profile defined by principal component analysis predicts acute rejection after kidney transplantation
por: Gaiffe, Emilie, et al.
Publicado: (2023)

Determinants of urgent start dialysis in a chronic kidney disease cohort followed by nephrologists
por: Tachikart, Amin, et al.
Publicado: (2023)

REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme
por: Ducloux, Didier, et al.
Publicado: (2022)

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients
por: Bamoulid, Jamal, et al.
Publicado: (2011)

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
por: Gaiffe, Emilie, et al.
Publicado: (2022)

Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
por: Ducloux, Didier, et al.
Publicado: (2021)

Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach
por: Ducloux, Didier, et al.
Publicado: (2022)

Transfused Red Blood Cell Characteristics and Kidney Transplant Outcomes Among Patients Receiving Early Posttransplant Transfusion
por: Gaiffe, Emilie, et al.
Publicado: (2023)

Polycystic kidney size and outcomes on peritoneal dialysis: comparison with haemodialysis
por: Courivaud, C., et al.
Publicado: (2014)

COVID-19–Related Collapsing Glomerulopathy in a Kidney Transplant Recipient
por: Lazareth, Hélène, et al.
Publicado: (2020)

Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
por: Gouin, Anna, et al.
Publicado: (2020)

PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled study
por: Gaiffe, E., et al.
Publicado: (2019)

End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation
por: Carron, Clémence, et al.
Publicado: (2019)

Exogenous melatonin as potential adjuvant in anti-SarsCov2 vaccines
por: Maestroni, Georges
Publicado: (2020)

ASSOCIATION BETWEEN CARDIOVASCULAR COMORBIDITIES AND MORTALITY AMONGST SARSCOV-2 PATIENTS
por: Douen, Aaron, et al.
Publicado: (2022)

SARSCOV-2 vaccine associated with primary cutaneous peripheral T cell lymphoma
por: Montoya, VH Garcia, et al.
Publicado: (2022)

Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020)

Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020)

(590) Sars_Cov2 Experience in the West Australian Heart Transplant Population
por: House, C., et al.
Publicado: (2023)

Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia
por: Oltolini, Chiara, et al.
Publicado: (2023)

Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020)

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)

Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020)

High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious?
por: Signorelli, Carlo, et al.
Publicado: (2020)

SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter
por: Xie, Lilan, et al.
Publicado: (2021)

SARSCoV-2 serostatus amongst vaccinated employees at a pediatric hospital system
por: Devaraj, Sridevi, et al.
Publicado: (2021)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Vaccination against SARSCoV-19 among psychiatric patients at the central Greek hospital
por: Anagnostaki, M. E., et al.
Publicado: (2023)

On the case report of Platypnea-orthodeoxia after SARSCoV-2 pneumonia plus historical notes
por: Corrêa, Paulo César Rodrigues Pinto
Publicado: (2020)

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?
por: Pelechas, Eleftherios, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tup52rknu2hh29fnf83rjnpgfm